注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
协和麒麟株式会社(原名:协和发酵麒麟株式会社)是一家主要从事医药生产和销售业务的日本公司。该公司通过两个业务部门运营。制药部门从事药品和其他产品的研究、开发、制造和销售业务。生物化学品部门主要从事氨基酸和核酸相关物质以及保健产品的药物和工业原料的研究、开发、制造和销售业务。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Masashi Miyamoto | 62 | 2011 | President, CEO & Representative Director |
Akira Morita | - | 2019 | Outside Independent Chairman |
Tomomi Yatsu | 63 | 2021 | Outside Independent Auditor |
Takeyoshi Yamashita | - | 2021 | Chief Medical Officer, Senior Managing Executive Officer & Director |
Yuko Haga | 69 | 2019 | Independent Outside Director |
Yutaka Osawa | 65 | 2017 | CCO, Executive VP & Representative Director |
Hiroshi Komatsu | 62 | 2018 | Full-time Audit & Supervisory Board Member |
Rumiko Nakata | 68 | 2023 | Independent Outside Director |
Shinjiro Akieda | 59 | 2024 | Director |
Yoshihisa Q. Suzuki | 69 | 2022 | Independent Outside Director |
Takashi Oyamada | 69 | 2021 | Independent Outside Director |
Tomomi Yatsu | 64 | 2021 | Outside Audit & Supervisory Board Member |
Mayumi Tamura | 64 | 2022 | Outside Audit & Supervisory Board Member |
Toru Ishikura | 61 | 2023 | Audit & Supervisory Board Member |
Hajime Kobayashi | 59 | - | Outside Audit & Supervisory Board Member |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核